Hypoxia promotes epithelial–mesenchymal transition in lung cancer cells via regulating the NRF2/miR‑27a/BUB1 pathway
Author:
Funder
Sichuan Federation of Social Science Associations
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12094-022-02965-x.pdf
Reference38 articles.
1. Jing X, et al., Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer, 2019. 18(1): p.157.
2. Verduzco D, Lloyd M, Xu L, Ibrahim-Hashim A, Balagurunathan Y, Gatenby RA, et al. Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance. PLoS ONE. 2015;10(3): e0120958.
3. Salem A, Asselin MC, Reymen B, Jackson A, Lambin P, West CML, O'Connor JPB, Faivre-Finn C. Targeting hypoxia to improve non-small cell lung cancer outcome. J Natl Cancer Inst. 2018;110(1):14–30.
4. Kuper A, Baumann J, Gopelt K, Baumann M, Sanger C, Metzen E, et al. Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis. Cell Death Dis. 2021;12(1):82.
5. Lee SL, Ryu H, Son AR, Seo B, Kim J, Jung SY, et al. TGF-beta and hypoxia/reoxygenation promote radioresistance of A549 lung cancer cells through activation of Nrf2 and EGFR. Oxid Med Cell Longev. 2016;2016:6823471.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modification;Life Sciences;2024-09
2. Exosomal miR-1228-5p down-regulates DUSP22 to promotes cell proliferation and migration in small cell lung cancer;Life Sciences;2024-08
3. Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies;Scientific Reports;2024-02-23
4. Wnt/β-catenin-driven EMT regulation in human cancers;Cellular and Molecular Life Sciences;2024-02-09
5. Nrf2 in human cancers: biological significance and therapeutic potential;American Journal of Cancer Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3